Angelman syndrome

Last updated: February 23, 2023

Angelman syndrome

HMBP Exam

HMBP Exam

Introduction to pharmacology
Light microscopy and staining methods
Cytoskeleton and intracellular motility
Pharmacodynamics: Agonist, partial agonist and antagonist
Cellular structure and function
Primary ciliary dyskinesia
Nuclear structure
DNA structure
Transcription of DNA
Translation of mRNA
Epigenetics
DNA damage and repair
DNA mutations
Rett syndrome
Amino acids and protein folding
Protein structure and synthesis
Osmosis
Myasthenia gravis
Cell membrane
Human development days 1-4
Human development days 4-7
Human development week 2
Selective permeability of the cell membrane
Prions (Spongiform encephalopathy)
Ehlers-Danlos syndrome
Osteogenesis imperfecta
Cystic fibrosis
Ectoderm
Mesoderm
Endoderm
Diabetes mellitus
Beta-thalassemia
Inheritance patterns
Independent assortment of genes and linkage
Mitosis and meiosis
Karyotyping
Glycolysis
Gluconeogenesis
Essential fructosuria
Hereditary fructose intolerance
Amino acid metabolism
Arsenic poisoning
Patau syndrome (Trisomy 13)
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Turner syndrome
Klinefelter syndrome
Angelman syndrome
Prader-Willi syndrome
Marfan syndrome
Citric acid cycle
Electron transport chain and oxidative phosphorylation
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Pentose phosphate pathway
Glycogen metabolism
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glycogen storage disease type V
Glycogen storage disease type IV
Glycogen storage disease type III
Ketone body metabolism
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Cri du chat syndrome
Williams syndrome
Fatty acid synthesis
Fatty acid oxidation
Nucleotide metabolism
Cystinosis
Antimetabolites for cancer treatment
Severe combined immunodeficiency
Lesch-Nyhan syndrome
Megaloblastic anemia
Hartnup disease
Cystinuria (NORD)
Drug administration and dosing regimens
Nitrogen and urea cycle
Cell cycle
Cholesterol metabolism
Fragile X syndrome
Huntington disease
Friedreich ataxia
Polycystic kidney disease
Achondroplasia
Neurofibromatosis
Albinism
Niemann-Pick disease types A and B (NORD)
Tay-Sachs disease (NORD)
Fabry disease (NORD)
Alkaptonuria
Ornithine transcarbamylase deficiency
Homocystinuria
Maple syrup urine disease
Krabbe disease
Gaucher disease (NORD)
Niemann-Pick disease type C
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Phenylketonuria (NORD)
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Wernicke-Korsakoff syndrome
Zellweger spectrum disorders (NORD)
Vitamin C deficiency
Adenosine deaminase deficiency
Xeroderma pigmentosum
Fanconi anemia
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
Gel electrophoresis and genetic testing
Fluorescence in situ hybridization
ELISA (Enzyme-linked immunosorbent assay)
Hardy-Weinberg equilibrium
Hemochromatosis
Alpha-thalassemia
Hemophilia
Muscular dystrophy
Mitochondrial myopathy
Pharmacokinetics: Drug absorption and distribution
Pharmacodynamics: Drug-receptor interactions

Transcript

Watch video only

Content Reviewers

Angelman syndrome is a genetic disorder that causes intellectual and developmental delay, seizures, frequent laughter, and ataxia, or poor control of voluntary movements.

Now, it happens when a gene on chromosome 15 called UBE3A is not expressed, or transcribed into messenger RNA.

UBE3A stands for ubiquitin-protein ligase E3A, and the protein it codes for is called E6AP or E6-associated protein.

The job of E6AP is to go around tagging, or attaching, a tiny protein called ubiquitin to other proteins, a process called ubiquitination.

Once that happens, the ubiquitinated protein is degraded by the proteasome, a part of the cell’s recycling machinery.

It’s kind of painting an orange U on a tree so that a lumberjack knows to chop it down.

So E6 associated protein has an important job, and it turns out that the region of chromosome 15 around UBE3A is imprinted, imprinting refers to gene expression that’s dependent on the parent of origin of a gene.

This means that either the maternally derived or paternally derived copy of the gene is silenced.

This differs from most genes in the genome, where both the maternal and paternal copies are expressed.

Normally, in the brain, only the maternally derived copy of UBE3A is expressed, while the paternal copy is silenced, unfortunately this process of imprinting leaves the maternal copy of UBE3A vulnerable.

So with the paternal copy of the gene imprinted, and epigenetically silenced, you’ve only got the maternal copy left.

So this means that if anything happens to the maternal copy, the result is Angelman syndrome.

There are a few different types of mutations that can cause Angelman syndrome.

The most common one is a deletion of a couple million base pairs of DNA on the maternal copy of chromosome 15 which includes UBE3A.

Sometimes the deletion overlaps a nearby gene called OCA2, which codes for a pigment that gives color to eye, hair, and skin.

As a result of this, these Angelman syndrome patients can have a light complexion.

A second way is a mutation within the maternal copy of UBE3A, making the protein ineffective.

A third way to get Angelman syndrome is when the entire maternal chromosome 15 is absent and instead there’s an extra copy of the paternal chromosome 15.

This scenario is called paternal uniparental disomy, which means that one parent – the father – contributed two of the same chromosome while the mother contributed none.

Key Takeaways

Angelman syndrome (AS) is a genetic neurodevelopmental disorder characterized by problems with motor skills, speech, developmental delay, and learning disabilities. People with AS typically have happy dispositions and frequently laugh or smile, even when they are not engaged in activities that would typically elicit such reactions.

Most individuals with AS do not develop fluent speech, have sleep disturbance, and usually have seizures. People with AS typically have a normal life expectancy and have the potential to improve on some self-help skills with proper supportive care.